Technology
Our Advantage
Proprietary Platform
We develop AI-designed biomaterials through our plant and protein-agnostic platform, ensuring high biocompatibility at significantly lower costs
IP Strategy
Our PCT pending Proprietary expression systems, design workflows, and platform Innovations sit at the core of our IP
Scalable Infrastructure
Our plant-based systems reduce reliance on expensive fermentation infrastructure and its lack of versatility due to optimisation requirements for each batch. Our proprietary expression systems enable 5x yield gains at high protein stability
Data-Driven Optimisation
Each production cycle improves future design through integrated data feedback.
Contact Us
For any enquiries or to learn more, please get in touch with us today:
The Future of Materials is Grown
LeafyColl is building the future of human identical biomaterials